Amaury Dewavrin

Directeur administratif et Financier ; VP Finance at Xenothera

Amaury Dewavrin has a diverse work experience spanning various industries and roles. Amaury is currently serving as the President of Le Foyer Notre-Dame des Sans-Abri since June 2023. Prior to this, they held the position of Administrative and Financial Director; VP Finance at Xenothera, starting from April 2021.

From September 2018 to April 2021, Amaury worked as the Vice-rector at the Université catholique de Lyon. Before that, they served as the Diocesan Economist at the Diocese of Lyon from March 2011 to October 2018.

In terms of entrepreneurship, Amaury was the owner of ESER/Régie publicitaire, Applications IPhone, PAO from September 2006 to July 2012, and also owned the Groupe des Éditions Municipales de France - GEMF from July 2005 to November 2010.

Amaury has experience at Groupe Hersant Media as a member of the Board of Directors, and held the role of Deputy General Manager at Comareg, where they led the reorganization and merger of the free press activities of the 3hersant" and "Comareg" groups.

Earlier in their career, Amaury served as the General Manager of Paris Normandie from 1998 to 2003, and as the Industrial Director at Ouest-France from 1986 to 1993.

Amaury Dewavrin's education history is as follows:

- In 1979, Amaury began attending École Polytechnique.

- From 1982 to 1984, Amaury studied at ENSAE Paris and obtained a High School degree.

- Amaury also attended Lycée Sainte-Geneviève, but the specific dates and field of study are unknown.

- Amaury received a Certificat administrateur de sociétés in Governance from Sciences Po. However, the dates of enrollment are not provided.

Location

Lyon, France

Links


Org chart


Teams

This person is not in any teams


Offices


Xenothera

Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments. Xenothera creates new therapeutic modes in numerous domains from immunomodulation to infectious diseases.Xenothera's technological platform is built on a double expertise of animal genetics and mastery of immunology processes. It renovatespassive immunotherapy by marketing a new generation of hyperimmune polyclonal sera.Xenothera’s platform ensures short-time development thanks to their mastery of the entire process, from animal genetics, choice of the immunogen, selection, and purification of interesting immunoglobulins, and access to market authorization in accelerated timescale.


Headquarters

Nantes, France

Employees

11-50

Links